| P50 | author | Zhong Chao Han | Q50636088 |
| P2093 | author name string | Jing Wang | |
| | Zhihong Wang | |
| | Xiaohong Li | |
| | Lixin Xu | |
| | Pei Liu | |
| | Dandan Zhao | |
| | Wanming Da | |
| | Chunji Gao | |
| | Xiaoxiong Wu | |
| | Yamei Wu | |
| | Pei Yan | |
| | Yongbin Cao | |
| | Zhouyang Liu | |
| P2860 | cites work | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study | Q29617267 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 |
| | Allogeneic hematopoietic stem cell transplantation: complications and results | Q30309645 |
| | Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors | Q33951486 |
| | A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. | Q34144404 |
| | Mesenchymal stem cells: heading into the clinic | Q34201234 |
| | Stem cells and aging: expanding the possibilities | Q34232196 |
| | Targeting the bone marrow microenvironment in hematologic malignancies | Q35800905 |
| | How I treat refractory acute GVHD. | Q35828633 |
| | Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting | Q35849125 |
| | Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. | Q36795165 |
| | Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation | Q40600413 |
| | Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution | Q43764320 |
| | Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies | Q43819615 |
| | Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia | Q44237334 |
| | Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft | Q44351338 |
| | Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain | Q45069979 |
| | Haploidentical stem cell transplantation: the always present but overlooked donor | Q46342941 |
| | A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome | Q47643486 |
| | Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 |
| P433 | issue | 12 | |
| P921 | main subject | umbilical cord mesenchymal stem cell | Q107296590 |
| P304 | page(s) | 1675-1684 | |
| P577 | publication date | 2013-07-11 | |
| P1433 | published in | Annals of Hematology | Q15766509 |
| P1476 | title | Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy | |
| P478 | volume | 92 | |